Clinical Trials
Eli Lilly Begins Phase III Study of RA Drug to Treat COVID-19
Eli Lilly will assess its JAK1/JAK2 inhibitor Olumiant (baricitinib) as a potential treatment for COVID-19 in a Phase III study.
Indianapolis-based Eli Lilly said the...
Clinical Trials
Atyr Pharma Announces Dosing Of First Patient In Phase 2 Trial Of ATYR1923 In Covid-19 Patients
aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, announced that it has...
Packaging & Labelling
Stevanato Group, SCHOTT, and Gerresheimer confirm the readiness to support future Covid-19 Vaccine with pharmaceutical containers
The CEOs of Gerresheimer, Stevanato Group, and SCHOTT are committed to ensuring ample supply of pharmaceutical containers for any Covid-19 vaccine and treatment that...
News
Corning Inc to expand Valor Glass production to accelerate delivery ahead of potential COVID-19 vaccines, treatments
Corning Inc. will receive $204 million in federal funding to expand manufacturing of its Corning Valor Glass packaging in order to expand production and...
Packaging & Labelling
UPS Healthcare Continues Global Facility Expansion To Meet Growing Demands In Key Markets
UPS announced a series of facility expansions to its healthcare-dedicated warehouse and distribution network in key global markets. This includes new GDP-compliant space opening...
News
Mobidiag Ltd Receives Second Tranche of €25M Financing from European Investment Bank
Mobidiag Ltd. announces that it has received the second tranche of €10M from the €25M growth capital loan signed with the European Investment Bank...
Clinical Trials
TrialSpark announces launch of Project Covalence, a clinical trial platform to rapidly test drugs and diagnostics for COVID-19
TrialSpark, a tech-enabled drug development company committed to improving the speed, quality, and innovation of clinical trials, announced the launch of Project Covalence, a...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read